PGY1 Pharmacy Residency Program at William Beaumont University Hospital

The purpose of the ASHP-accredited Corewell Health William Beaumont University Hospital post-graduate year one (PGY1) pharmacy residency is to build on doctor of pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

The PGY1 residency program at Corewell Health William Beaumont University Hospital will foster the development of competent and confident pharmacists. As a member of the health care team, residents will be responsible for providing direct patient care to multiple populations. They will exercise skill in educating health care professionals and patients on medication related topics. Residents will solve practice-related problems in a time sensitive manner through critical thinking skills. Residents will demonstrate professional maturity by following a personal philosophy of practice, monitoring their own performance, exhibiting commitment to the profession and exercising leadership in improving the safety of the medication use system. Lastly, residents will possess the knowledge and leadership skills to promote the advancement of the practice of pharmacy.

• Core structure: individualized learning experiences, clinical and operational staffing and longitudinal requirements
• Individualized resident development plan to accomplish both program and resident-identified goals

• Advisor program where each resident selects an advisor for the year
• Opportunity to participate in a teaching certificate program
• Chief resident and other chair positions available
• Early commit option for PGY2 resident positions in ambulatory care, critical care, infectious diseases
  • A PGY2 position in emergency medicine and PGY1/PGY2 HSPAL combined program are also available through the traditional match process
• Longitudinal leadership and preceptor development program
• Research training program
• In-house on-call program

The 54 week long residency program is divided into eleven one-month experiences following a six-week orientation dedicated to operational areas and clinical services.  Refer to the "rotations" section for required, selective, and elective learning experiences. PGY1 Residents at Corewell Health William Beaumont University are also required to complete a number of longitudinal requirements.

• Participate in residency recruitment activities
• Present at department educational conference
• Deliver Royal Oak pharmacy grand rounds to Royal Oak pharmacy department team members
• Develop and deliver a one-hour accredited continuing education presentation
• Complete a medication utilization evaluation (MUE) research project
  • Present MUE results in poster format at ASHP midyear clinical meeting or Vizient pharmacy network resident poster session
  • Present research project results as a platform presentation at a regional residency conference
• Develop manuscript for MUE research project suitable for publication submission
• Weekend staffing (every 3rd weekend and two holidays)
• Complete on-call program requirements
• Precept doctor of pharmacy students
• Participate in leadership development program
• Optional: Participate in Wayne State University teaching and learning certificate program

*Program requirements are subject to change at the discretion of the residency program director and RACS

• Attend the Michigan Society of Health System Pharmacists annual meeting

• Present at the ASHP midyear clinical meeting *
• Present at a regional pharmacy residency conference *

*Approved financial support for travel to conferences is at the discretion of the organization.

Our inpatient pharmacy department utilizes an integrative practice model, where pharmacists have responsibilities for both distributive and clinical functions. Advancement of our practice model includes the incorporation of state-of-the-art technological systems and a comprehensive electronic medical record.

Ambulatory care pharmacy services include: anticoagulation, diabetes, transitions of care management, pharmacist clinic (collaborative practice agreement to provide medication management for patients with diabetes, hypertension, hyperlipidemia, asthma/COPD, smoking cessation, etc.) and infectious diseases clinics.

Our residency preceptors are actively engaged in practice, education and scholarship. The majority of preceptors hold adjunct appointments with Wayne State University, Eugene Applebaum College of Pharmacy and Allied Health Professions, the University of Michigan, and/or the Oakland University William Beaumont School of Medicine and enjoy productive collaborative relationships with these key partners.

In recognition of their accomplishments, members of our pharmacy team have received external recognition of excellence at the local, state, and national level. Our preceptors hold fellow status within national professional organizations as well as discipline-specific and specialty board certification.

Additional awards include:

• Warrior Preceptor of the Year Award, Wayne State University College of Pharmacy and Health Sciences 2025 Lucas Shelly, PharmD, MSPGx, Clinical Pharmacist; recognized for demonstrating commitment and excellence in providing exceptional experiential education, promoting an environment that fosters and facilitates student learning, and displaying leadership and service to patients and the profession 
• Toby Clark Resident Research Award Nominee, Ohio Pharmacy Resident Conference 2024 Athena Chukwu, PharmD, Non-Traditional PGY1 Pharmacy Resident; nominated for demonstrating excellence in pharmacy practice research
• Toby Clark Resident Research Award, Ohio Pharmacy Resident Conference 2022 Anthony Patros, Pharm.D., past Non-Traditional PGY1 Pharmacy Resident; awarded for demonstrating excellence in pharmacy practice research
• Pharmacist of the Year Award, Southeastern Michigan Society of Health-System Pharmacists 2020 Christy Yost, Pharm.D., BCID Clinical Pharmacy Specialist – Infectious Diseases; recognized for exemplary working relationships with all disciplines and innovative approaches to problem solving
• Resident of the Year Award, Southeastern Michigan Society of Health-System Pharmacists 2020 Andrew Torey, Pharm.D., past PGY1 Pharmacy Resident, current Integrated Practice Experience preceptor; recognized for his contributions to the professional practice of health-system pharmacy
• Warrior Preceptor of the Year Award, Wayne State University College of Pharmacy and Health Sciences 2019
  Jenna Holzhausen, PharmD, BCPS, Clinical Pharmacy Specialist – Critical Care; recognized for demonstrating commitment and excellence in providing exceptional experiential education, promoting an environment that fosters and facilitates student learning, and displaying leadership and service to patients and the profession
• Two-year, $1 million dollar grant, Michigan Opioid Partnership Fund of the Community Foundation for Southeast Michigan
  Levi Hall, Pharm.D.,BCPS, Clinical Pharmacy Specialist – Pain Medicine and team; grant was awarded to help establish an Addiction Medicine Program at Beaumont Hospital, Royal Oak
• Clinical Nutrition Team of Distinction Award, American Society for Parenteral and Enteral Nutrition 2018
  Sandy Kless, Pharm.D., BCNSP, – Clinical Pharmacy Specialist – Nutrition Support and team; recognized for excellence in interdisciplinary clinical nutrition practice in institutions or agencies who meet certain criteria and compliance with ASPEN national standards, guidelines and value
• Preceptor of the Year Award, Southeastern Michigan Society of Health-System Pharmacists 2017
  Megan Cadiz, Pharm.D., Clinical Pharmacy Specialist – Critical Care; recognized for excellence in health-system pharmacy practice and commitment to providing quality experiential opportunities for pharmacy students and residents
• Resident of the Year  Award, Southeastern Michigan Society of Health-System Pharmacists 2017
  Kirsten Wallskog, Pharm.D., PGY1 Pharmacy Resident; recognized for her contributions to the professional practice of health-system pharmacy
• Exemplary Student Award, Southeastern Michigan Society of Health-System Pharmacists 2016- Rachael Fuller, past Wayne State University Pharm.D. Candidate, current Integrated Practice Experience Preceptor
• Exemplary Resident Continuing Education (CE) Lecture, Southeastern Michigan Society of Health-System Pharmacists 2016
  Julie Francisco, Pharm.D.; recognized for outstanding resident CE presentation
• Pharmacist of the Year, Michigan Society of Health-System Pharmacists 2015
  Mark Lutz, Pharm.D. CPPS, Drug Information & Medication Safety Specialist; recognized for his contributions to medication safety at the local, state and national level
• Student Research Award, Southeastern Michigan Society of Health-System Pharmacists 2014
  Alex Chaben, Pharm.D. Candidate, Wayne State University and  Pharmacy Intern, Beaumont, Royal Oak; recognized for his work on evaluating inpatient anticoagulant hemorrhage
• Innovative Practice Award, Southeastern Michigan Society of Health-System Pharmacists 2012
  Awarded to pharmacists at Beaumont for improving outcomes of patients with Heparin Induced Thrombocytopenia

The PGY1 residency program at Corewell Health William Beaumont University Hospital consists of seven required learning experiences, at least 1 selective learning experience, up to 3 elective learning experiences, and several required longitudinal learning experiences. Residents may repeat any learning experience as an elective (with the exception of orientation and internal medicine). The current required, selective, elective, and longitudinal learning experiences are outlined below:

• Orientation (6 weeks)
• Ambulatory care
• Critical care (medical, surgical, cardiac)
• Drug information
• Integrated practice experience
• Internal medicine
• Practice management

• Critical care - 2 (different population)
• Emergency medicine
• Infectious diseases consult service
• Nutrition support
• Inpatient hematology/oncology
• Solid organ transplant (SOT)

• Academics
• Ambulatory care – 2
• Antimicrobial stewardship
• Informatics
• Investigational drug service
• Medication safety
• Operating room pharmacy
• Pediatric infectious diseases
• Pediatric ICU (PICU)
• Specialty pharmacy
• Transitions of care

• Continuing education lecture
• Medication use evaluation (MUE) research project
• On-call program
• Staffing

Coverage includes:

• Medical
• Dental
• Vision
• Prescription drug
• Life and disability insurance

• Library access

• Resident office
• Dedicated desk space and computer
• Pharmacy continuing education
• Free parking
• Mentorship program

Approved travel to conferences is at the discretion of the organization.  Previously attended conferences have included the ASHP Midyear Clinical Meeting and Ohio Pharmacy Residency Conference if travel funding is available. If travel approved, paid travel expenses (hotel, registration, transportation) for each conference will typically be approved up to $3,000. If expenses are expected to exceed $3,000, approval will be determined on a per-case basis. 

The anticipated salary for incoming residents is approximately $58,700/year.  

Residents will accrue paid time off (PTO) throughout the year. Residents can take up to 10 days of vacation throughout the year. Additional PTO days may be taken for PGY2 or job interviews. No more than 3 days of PTO may be used during any one rotation.

Arianna Jalics
Hometown: Ray, MI
Undergraduate degree: N/A
Pharmacy degree: Doctor of pharmacy, Butler University College of Pharmacy and Health Sciences 
Clinical interests: Critical care and infectious diseases 
Personal interests: Trying new restaurants, running, being outdoors, spending time with family and friends 

Olivia Li
Hometown: Columbus, OH
Undergraduate degree: Bachelor's of science in pharmaceutical sciences, The Ohio State University
Pharmacy degree: Doctor of pharmacy, The Ohio State University College of Pharmacy
Clinical interests: Ambulatory care, hematology/oncology, internal medicine, informatics
Personal interests: Watching documentaries, listening to podcasts, playing video games with friends, eating good food

Anna Mills
Hometown: Clinton, IL
Undergraduate degree: N/A
Pharmacy degree: Doctor of pharmacy, Southern Illinois University of Edwardsville
Clinical interests: Infectious diseases, critical care, and women's health
Personal interests: Reading, baking, crocheting, and spending time with family and my cats (Gwen, Apollo, Athena)

Divya Thomas
Hometown: Plymouth, MI
Undergraduate degree: Bachelor's of science in pharmaceutical sciences, University of Toledo
Pharmacy degree: Doctor of pharmacy, University of Toledo
Clinical interests: Critical care, internal medicine, cardiology
Personal interests: Baking, spending time with family and friends, playing pickleball, watching Detroit sports

Noah Wegener
Hometown: Caledonia, MI
Undergraduate degree: Bachelor of science (health sciences), University of Alaska Anchorage
Pharmacy degree: Doctor of pharmacy, University of Michigan College of Pharmacy
Clinical interests: Infectious diseases, hematology/oncology
Personal interests: Listening to music, concerts, collecting records, watching sports, spending time with family and friends

Rachelle Wendt
Hometown: Port Huron, MI
Undergraduate degree: Bachelor's in biomolecular science, University of Michigan
Pharmacy degree: Doctor of pharmacy, University of Michigan College of Pharmacy
Clinical interests: Emergency medicine, critical care, internal medicine
Personal interests: Traveling, watching football, working out, and playing with my dog, Moose

Brendan Bectel (HSPAL)
Hometown: Spring Lake, MI
Undergraduate degree: Associate of science, Ferris State University
Pharmacy degree: Doctor of pharmacy, Ferris State University College of Pharmacy
Clinical interests: Administration and leadership, managed care, and population health
Personal interests: Spending time with friends and family including my wife and two cats, as well as gaming, golfing and playing darts

• Adjunctive Therapy of Gabapentin in Alcohol Withdrawal Syndrome
• Comparative Analysis of Fixed versus Variable Dosing of Regional Citrate Anticoagulation in Critically Ill Patients on Continuous Kidney Replacement Therapy  
• Impact of preprocedural sodium-glucose cotransporter-2 inhibitor hold time on the incidence of adverse effects  
• Evaluation of Argatroban INR Elevation and Transition to Warfarin in Acute HIT
• Efficacy and Safety of IV Heparin Protocol for Acute VTE in Obese Patients
• Four Factor Prothrombin Complex Concentrate (4FPCC) versus Activated 4PCC for Acute Direct Xa Inhibitor Bleeding
• Inpatient Use of SGLT2 inhibitors and Effect on Heart Failure
• Evaluation of Glucose Management in Patients Undergoing Cardiac Surgery
• Impact of Early Administration of Long-Acting Insulin in Diabetic Ketoacidosis
• Safety and Efficacy of Early Antibiotic Discontinuation in Febrile Neutropenic Patients with Fever of Unknown Origin 
• Levetiracetam for Seizures Prophylaxis in Spontaneous Intracerebral Hemorrhage
• Evaluation of Hydrocortisone Dosing in the Management of Septic Shock in Adults 
• Safety and Efficacy of Digoxin Loading Doses in Renal Insufficiency 
• Impact of Staphylococcus aureus Nasal Screening on Antimicrobial Therapy in Non-Purulent Skin and Soft Tissue Infections
• Antimicrobial Prescribing Practices from Hospital to Home for Community Acquired Pneumonia (CAP) and Urinary Tract Infection (UTI)
• Continuous Infusion Ketamine for Sedation in Mechanically Ventilated COVID-19 Patients
• Metoprolol vs. Diltiazem in Heart Failure Patients with Atrial Fibrillation with Rapid Ventricular Response
• Impact of Pharmacist-Initiated Lithium Counseling on Lithium Toxicity and Retention of Knowledge about Lithium
• Impact of Daily Pharmacist Review of Antimicrobial Agent Dosing in Continuous Renal Replacement Therapy
• The impact of switching from trough-guided to AUC guided vancomycin dosing on hospital resources
• Evaluation of the efficacy and safety of warfarin vs. DOACs after bioprosthetic valve replacement
• Comparison of argatroban vs. heparin for VV-ECMO anticoagulation and the impact on patient outcomes and safety
• De-escalation of empiric vancomycin for pneumonia driven by pharmacist ordering of MRSA nasal screen
• Impact of MRSA PCR assay and MRSA nasal culture on de-escalation of empiric vancomycin therapy for pneumonia
• Risk factors for high-dose methotrexate-induced nephrotoxicity in the treatment of hematologic malignancies
• Evaluation of cephalexin for treatment of acute uncomplicated cystitis in patients discharged home from the emergency department
• Evaluating the Effectiveness of Oral Antibiotics for Definitive Treatment of Enterobacteriaceae Associated Bloodstream Infections
• Characterizing medical residents’ opioid prescribing patterns before and after the implementation of new opioid laws
• Assessing Oral Anticoagulation after an Acute Ischemic Stroke
• Evaluating Antipsychotic Use for ICU Delirium in an Academic Medical Center
• Assessing Adherence to the Medication Components of the Severe Sepsis 3 and 6 – hour Resuscitation Bundle for the Treatment of Sepsis, Severe Sepsis, and Septic Shock
• Comparing Catheter-Directed Alteplase vs. Systemic Alteplase 100mg v. Systemic Alteplase 50mg Associated Bleeds
• Apixaban Major Bleeding in Atrial Fibrillation:  Patient Characteristics, Management and Outcomes
• Clinical and Economic Outcomes of Warfarin Versus Direct Oral Anticoagulants (DOACs) Following Alteplase for the Treatment of Pulmonary Embolism (PE)
• Hemodynamic Effects of Dexmedetomidine Compared to Propofol in Critically Ill Adults
• Evaluation of De-Escalation of Empirically Initiated Broad-Spectrum Antibiotics in Patients Diagnosed with Healthcare-Associated Pneumonia
• Evaluation of Compliance to an Intravenous Insulin Infusion Protocol in the Management of Diabetic Ketoacidosis
• Evaluation of Specialty Pharmacy Services and Treatment Outcomes for Hepatitis C at a Large Academic Medical Center
• An Economic Evaluation Comparing Three Different Regimens (Moxifloxacin vs. Levofloxacin vs. Ceftriaxone/Azithromycin) for the Treatment of Community Acquired Pneumonia
• Development, Optimization and Implementation of Trigger Tool Methodology to Improve Identification of Adverse Medication Events
• Safety and Efficacy of Early Antibiotic Discontinuation in Febrile Neutropenic Patients with Fever of Uknown Origin
• Impact of Early Administration of Long-Acting Insulin in Diabetic Ketoacidosis
• Inpatient Use of Sodium-Glucose Cotransporter-2 Inhibitors and the Effect on Heart Failure
• Evaluation of Glucose Management in Patients Undergoing Cardiac Surgery

Virtual open house event - November

• Wednesday, November 19th from 2:00 – 4:00 PM EST
• Register here 
• Open house Zoom link 

Residency showcase at the 2025 ASHP Midyear Clinical Meeting 

• Tuesday, December 9th from 8:00 – 11:00 AM PST
• Booth 5048

Virtual open house event - December

• Wednesday, December 17th from 2:00 – 4:00 PM EST
• Register here 
• Open house Zoom link

The third Monday of June each year.

We welcome applications from non-U.S. citizens who have a “green card” (permanent resident status) or a current visa valid through the entire duration of the residency program (~54 weeks). The Corewell Health William Beaumont University Hospital  PGY1 pharmacy residency program is unable to sponsor visas for pharmacy residents.

Corewell Health William Beaumont University Hospital offers a two-year non-traditional (NT) PGY1 residency program.  Applicants must be a Corewell Health William Beaumont University Hospital pharmacist for at least 1 year prior to the residency program start date. The program accepts up to two residents every two years. The next recruitment for the NT PGY1 residency program will be for the 2026-2028 non-traditional residency cycle.

• Residents are expected to play an active role in precepting doctor of pharmacy students who are scheduled on rotation with them. Corewell Health receives students from a number of different colleges of pharmacy
• Residents deliver several oral presentations to the pharmacy department staff throughout their learning experiences. These presentations fall into the categories of pharmacy grand rounds, journal clubs, topic discussions, and case presentations
• Residents provide an accredited continuing education lecture to Corewell Health pharmacy employees
• Residents interested in teaching can select the academics learning experience as an elective
• Residents have the opportunity to participate in a resident teaching and learning curriculum certificate program offered in conjunction with Wayne State University

Residents will have staffing responsibilities every third weekend and two holidays of the year.

All residents entering the program should strive to be fully licensed by their start date. NOTE: in recent years, it has taken the Michigan Board of Pharmacy 4-6 weeks to process licensure applications.

Incoming PGY1 residents not fully licensed or not having confirmed examination dates prior to the program start date, and who do not have confirmed examination dates prior to their program start date, must contact the PGY1 residency program director PRIOR to the residency start date to create a written plan for licensure. Individuals who fail to meet the licensure deadlines will be evaluated by the RPD and the residency advisor committee, as appropriate. Program extension may be considered, and residency training plans may be modified to accommodate licensure delays, including but not limited to, adjustments to staffing, on-call and rotation schedules. If the resident is not licensed within 120 days after the program start date, the resident will be dismissed from the program.

*Program requirements are subject to change at the discretion of the residency program director and advisory committee.

• Ask your pharmacy school to submit the “certificate of pharmacy education” form to the NABP as soon as possible after graduation
• Go to the NABP website and create an account and apply for the exam
• Upon receiving your authorization to test (ATT),schedule your examination for the earliest date possible (prior to your residency start date). It is expected that incoming residents will drive up to 120 miles (2 hours) to identify a testing center with an available date
• Once confirmed, email your exam date to the PGY1 residency program director
• Once you receive your passing scores, apply for the Michigan pharmacist and controlled substance licenses
  • MIPLUS Application Website
  • NOTE: the State of Michigan requires licensure applicants to have completed training in several areas prior to applying for licensure (i.e., opioids and controlled substance awareness, human trafficking, implicit bias, etc.). It is the resident’s responsibility to ensure completed training courses meet the standards established in published administrative rules. The residency program nor the state endorses any specific training program. Questions about these requirements should be directed to Bureau of Professional Licensing within the Department of Licensing and Regulatory Affairs (LARA)

• National Association of Boards of Pharmacy (NAPLEX & Information)
• State of Michigan Department of Licensing and Regulatory Affairs (LARA) 

Corewell Health William Beaumont University Hospital is located in the city of Royal Oak, Michigan approximately 15 miles north of Detroit. Located in Oakland County, Royal Oak’s close proximity to major freeways make it a convenient place to work and live. Royal Oak has the appeal of a small town with a growing downtown area. Downtown Royal Oak offers a wide variety of specialty shops, restaurants and entertainment. Many affordable options for housing are available in the surrounding areas.

In addition, Birmingham, Clawson, Troy and Berkley are all located close to the hospital and are other areas to consider in your housing search.

Local attractions

• Detroit Opera House
• Detroit Symphony Orchestra - Max M. Fisher Music Center
• Emagine Theatre - Royal Oak
• Fox Theatre
• Detroit Institute of Arts
• Detroit Zoo
• The Henry Ford Museum and Greenfield Village
• Royal Oak Arts, Beats and Eats Festival
• Downtown Birmingham
• Downtown Royal Oak
• Somerset Collection
• Comerica Park - Detroit Tigers and outdoor concerts and events
• Ford Field - Detroit Lions, concerts, and events
• Little Caesar's Arena - Detroit Pistons, Red Wings, and concerts
• Pine Knob - outdoor concerts
• Woodward Dream Cruise

NOTE: Corewell Health has multiple residency programs. The traditional PGY1 program based at Corewell Health William Beaumont University Hospital is listed as ASHP program #43600 in the online ASHP Residency Directory. Please ensure you are applying to the desired program. 

Residency candidates must be a graduate of a college of pharmacy accredited in the U.S. and must be eligible for licensure in the State of Michigan. Candidates must also register for the Matching Program and have a National Matching Services (NMS) applicant number.

Interested candidates must submit the following materials via PhORCAS:

• Curriculum vitae
• Letter of intent
• Three letters of recommendation (letters from at least 2 clinical preceptors preferred)
• Transcripts from college of pharmacy

All application materials must be received by January 2, 2026.

Direct any questions about the PGY1 residency program to:

Allycia Marie, Pharm.D
Clinical pharmacy specialist, critical care
PGY1 residency program director
Corewell Health William Beaumont University Hospital
Department of Pharmaceutical Services
3601 West 13 Mile Rd.,
Royal Oak, MI 48073
Phone: 248.898.5878
Fax: 248.898.4046